Association of preoperative depression and survival after resection of malignant brain astrocytoma

Surgical Neurology

Volumn 71, Issue 3, 2009, Pages 299-303

  Gathinji, Muraya ^a,b   McGirt, Matthew J ^a,b   Attenello, Frank J ^a,b   Chaichana, Kaisorn L ^a,b   Than, Khoi ^a,b   Olivi, Alessandro ^a,b   Weingart, Jon D ^a,b   Brem, Henry ^a,b   Quinones Hinojosa, Alfredo ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Neuro Oncology Surgical Outcomes Research Laboratory   (United States)

Author keywords

Depression; Disability; Glioblastoma multiforme; Survival

Indexed keywords

CARMUSTINE; TEMOZOLOMIDE;

ARTICLE; BRAIN SURGERY; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; DEPRESSION; DISEASE ASSOCIATION; DRUG IMPLANTATION; GLIOBLASTOMA; HUMAN; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREOPERATIVE DEPRESSION; TUMOR BIOPSY;

ADULT; AGED; ASTROCYTOMA; BRAIN NEOPLASMS; DEPRESSION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MORBIDITY; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 60649089537     PISSN: 00903019     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surneu.2008.07.016     Document Type: Article

References (36)

1. Aalto T.J., Malmivaara A., Kovacs F., et al. Preoperative predictors for postoperative clinical outcome in lumbar spinal stenosis: systematic review. Spine 31 (2006) E648-E663
2. Black K.L., Chen K., Becker D.P., et al. Inflammatory leukocytes associated with increased immunosuppression by glioblastoma. J Neurosurg 77 (1992) 120-126
3. Blazer D.G., Kessler R.C., McGonagle K.A., et al. The prevalence and distribution of major depression in a national community sample: the National Comorbidity Survey. Am J Psychiatry 151 (1994) 979-986
4. Brown P.D., Maurer M.J., Rummans T.A., et al. A prospective study of quality of life in adults with newly diagnosed high-grade gliomas: the impact of the extent of resection on quality of life and survival. Neurosurgery 57 (2005) 495-504 [discussion 495-504]
5. Capuron L., Gumnick J.F., Musselman D.L., et al. Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26 (2002) 643-652
6. Carney C.P., Jones L., Woolson R.F., et al. Relationship between depression and pancreatic cancer in the general population. Psychosom Med 65 (2003) 884-888
7. Davis F.G., McCarthy B.J., Freels S., et al. The conditional probability of survival of patients with primary malignant brain tumors: surveillance, epidemiology, and end results (SEER) data. Cancer 85 (1999) 485-491
8. Fisher P.G., and Buffler P.A. Malignant gliomas in 2005: where to GO from here?. JAMA 293 (2005) 615-617
9. Fras I., Litin E.M., and Pearson J.S. Comparison of psychiatric symptoms in carcinoma of the pancreas with those in some other intra-abdominal neoplasms. Am J Psychiatry 123 (1967) 1553-1562
10. Friedman G.D. Psychiatrically-diagnosed depression and subsequent cancer. Cancer Epidemiol Biomarkers Prev 3 (1994) 11-13
11. Gotay C.C., Korn E.L., McCabe M.S., et al. Quality-of-life assessment in cancer treatment protocols: research issues in protocol development. J Natl Cancer Inst 84 (1992) 575-579
12. Hjerl K., Andersen E.W., Keiding N., et al. Depression as a prognostic factor for breast cancer mortality. Psychosomatics 44 (2003) 24-30
13. Irwin M.R. Depression and risk of cancer progression: an elusive link. J Clin Oncol 25 (2007) 2343-2344
14. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
15. Leonard B.E. Inflammation, depression and dementia: are they connected?. Neurochem Res 32 (2007) 1749-1756
16. Litofsky N.S., Farace E., Anderson Jr. F., et al. Depression in patients with high-grade glioma: results of the Glioma Outcomes Project. Neurosurgery 54 (2004) 358-366 [discussion 366-357]
17. Loberiza Jr. F.R., Rizzo J.D., Bredeson C.N., et al. Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases. J Clin Oncol 20 (2002) 2118-2126
18. Louis D.N., Ohgaki H., Wiestler O.D., et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114 (2007) 97-109
19. Maes M., Meltzer H.Y., Bosmans E., et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J Affect Disord 34 (1995) 301-309
20. Mainio A., Hakko H., Timonen M., et al. Depression in relation to survival among neurosurgical patients with a primary brain tumor: a 5-year follow-up study. Neurosurgery 56 (2005) 1234-1241 [discussion 1241-1232]
21. Mainio A., Tuunanen S., Hakko H., et al. Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: a follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci 256 (2006) 516-521
22. McGee R., Williams S., and Elwood M. Depression and the development of cancer: a meta-analysis. Soc Sci Med (1982) 38 (1994) 187-192
23. Morford L.A., Elliott L.H., Carlson S.L., et al. T cell receptor-mediated signaling is defective in T cells obtained from patients with primary intracranial tumors. J Immunol 159 (1997) 4415-4425
24. Nakaya N., Saito-Nakaya K., Akizuki N., et al. Depression and survival in patients with non-small cell lung cancer after curative resection: a preliminary study. Cancer Sci 97 (2006) 199-205
25. Peterson K. Brain tumors. Neurol Clin 19 (2001) 887-902
26. Pringle A.M., Taylor R., and Whittle I.R. Anxiety and depression in patients with an intracranial neoplasm before and after tumour surgery. Br J Neurosurg 13 (1999) 46-51
27. Reiche E.M., Nunes S.O., and Morimoto H.K. Stress, depression, the immune system, and cancer. Lancet Oncol 5 (2004) 617-625
28. Schiepers O.J., Wichers M.C., and Maes M. Cytokines and major depression. Prog Neuro-Psychopharmacol Biol Psychiatry 29 (2005) 201-217
29. Sinikallio S., Aalto T., Airaksinen O., et al. Depression is associated with poorer outcome of lumbar spinal stenosis surgery. Eur Spine J 16 (2007) 905-912
30. Spiegel D., and Giese-Davis J. Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54 (2003) 269-282
31. Stommel M., Given B.A., and Given C.W. Depression and functional status as predictors of death among cancer patients. Cancer 94 (2002) 2719-2727
32. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 (2005) 987-996
33. Thaker P.H., Han L.Y., Kamat A.A., et al. Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nat Med 12 (2006) 939-944
34. Vasiliadis H.M., Lesage A., Adair C., et al. Do Canada and the United States differ in prevalence of depression and utilization of services?. Psychiatr Serv 58 (2007) 63-71
35. Weitzner M.A. Psychosocial and neuropsychiatric aspects of patients with primary brain tumors. Cancer Invest 17 (1999) 285-291 [discussion 296-287]
36. Zonderman A.B., Costa Jr. P.T., and McCrae R.R. Depression as a risk for cancer morbidity and mortality in a nationally representative sample. JAMA 262 (1989) 1191-1195